Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluconazole vs Ketoconazole for Esophageal Candidiasis
NCT00002304Phase 3Completed
- Sponsor
- Pfizer
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 3 trial of fluconazole in esophageal candidiasis, sponsored by Pfizer. Status: completed.
02
Drugs
fluconazole
03
Conditions
esophageal candidiasis
Beyond the preview
Go deeper on NCT00002304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002304.